Over the past 32 years ChemDiv has successfully completed hundreds of leads, candidates and new drug programs to treat cancer, neurological, infectious, cardiometabolic and immune diseases with pharma, biotech and academic partners around the globe. We are revolutionizing the field of drug discovery by harnessing the power of Hybrid Artificial Intelligence (AI) /Machine Learning (ML) which is curated by our scientists at each step in the process.